# Siliq

NDC: 0187-0004
Generic name: Brodalumab
Labeler / Manufacturer: Bausch Health US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20170215

FDA application: BLA761032

## Active ingredients

- BRODALUMAB: 210 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0187-0004"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0187-0004
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a550c33-456a-4833-814e-8591aea7c688